VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
IRON
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
IRONDisc Medicine, Inc.
$74.50$2.8B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksIRONQuarterly Financials

Disc Medicine, Inc. (IRON) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Disc Medicine, Inc. (IRON) quarterly income statement — complete revenue, gross profit & net income history

IRON Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue00000000000000000000
Revenue Growth %--------------------
Cost of Goods Sold89K087K009K00000000000000
COGS % of Revenue--------------------
Gross Profit-89K0-87K00-9K00000000000000
Gross Margin %--------------------
Gross Profit Growth %-100%------------------
Operating Expenses69.44M66.97M67.61M61.41M39.95M34.54M32.86M30.85M31.46M29.71M18.96M17.33M25.13M21.33M10.48M12.02M9.96M17.74M18.45M16.32M
OpEx % of Revenue--------------------
Selling, General & Admin23.62M20.75M17.36M15.09M12.18M9.75M8.17M7.37M7.76M7.15M4.54M5.23M4.95M712K2.59M4.3M2.14M5.11M5M5.48M
SG&A % of Revenue--------------------
Research & Development45.81M46.22M50.25M46.32M27.76M24.79M24.68M23.48M23.7M22.57M14.42M12.1M20.18M20.61M7.89M7.71M7.82M12.63M13.46M10.84M
R&D % of Revenue--------------------
Other Operating Expenses00000000000000000000
Operating Income-69.52M-66.97M-67.7M-61.41M-39.95M-34.55M-32.86M-30.85M-31.46M-29.71M-18.96M-17.33M-25.13M-21.33M-10.48M-12.02M-9.96M-17.74M-18.45M-16.32M
Operating Margin %--------------------
Operating Income Growth %-74.05%-93.84%-106.04%-99.05%-26.97%-16.28%-73.31%-78.05%-25.22%-39.33%-80.91%-44.22%-152.26%-20.21%43.2%26.38%39.6%-348.77%--
EBITDA-69.44M-66.88M-67.61M-61.33M-39.93M-34.54M-32.84M-30.74M-31.44M-29.69M-18.93M-17.3M-25.1M-21.24M-10.46M-11.99M-9.94M-17.7M-18.39M-16.26M
EBITDA Margin %--------------------
EBITDA Growth %-73.91%-93.63%-105.84%-99.48%-27.01%-16.34%-73.48%-77.67%-25.24%-39.79%-81.09%-44.28%-152.46%-20.02%43.15%26.23%39.47%-345.13%--
D&A (Non-Cash Add-back)89K89K87K85K20K9K11K110K26K25K25K25K25K89K24K22K18K46K58K62K
EBIT-69.52M-59.56M-61.3M-54.28M-33.07M-13.26M-32.86M-26.29M-26.94M-29.71M-18.96M-17.33M-25.13M-22.03M-10.48M-12.02M-9.96M-17.74M-18.45M-16.33M
Net Interest Income6.89M6.53M5.5M6.15M5.98M5.27M6.36M4.57M4.52M4.68M4.84M2.91M2.37M52K269K45K7K-81K-99K-116K
Interest Income6.89M7.41M6.41M7.06M6.88M5.84M6.36M4.57M4.52M4.68M4.84M2.91M2.37M52K269K45K7K4K5K5K
Interest Expense0883K917K910K897K572K0000000----85K104K121K
Other Income/Expense6.07M6.53M5.48M6.21M5.98M5.27M6.37M4.56M4.52M6.17M4.86M1.41M2.37M98K-5.67M2.44M107K-81K-101K-127K
Pretax Income-63.45M-60.44M-62.22M-55.2M-33.97M-29.28M-26.48M-26.29M-26.94M-23.55M-14.1M-15.92M-22.76M-21.23M-16.15M-9.58M-9.85M-17.82M-18.55M-16.45M
Pretax Margin %--------------------
Income Tax51K88K102K52K119K176K114K60K5K32K20K24K23K0000000
Effective Tax Rate %-0.08%-0.15%-0.16%-0.09%-0.35%-0.6%-0.43%-0.23%-0.02%-0.14%-0.14%-0.15%-0.1%0%0%0%0%0%0%0%
Net Income-63.5M-60.53M-62.32M-55.25M-34.09M-29.46M-26.6M-26.35M-26.95M-23.58M-14.12M-15.95M-22.78M-21.23M-16.15M-9.58M-9.85M-17.82M-18.55M-16.45M
Net Margin %--------------------
Net Income Growth %-86.31%-105.49%-134.3%-109.65%-26.48%-24.93%-88.35%-65.25%-18.3%-11.07%12.56%-66.46%-131.21%-19.11%12.94%41.75%48.27%-293.93%--
Net Income (Continuing)-63.5M-60.53M-62.32M-55.25M-34.09M-29.46M-26.6M-26.35M-26.95M-23.58M-14.12M-15.95M-22.78M-21.23M-16.15M-9.58M-9.85M-17.82M-18.55M-16.45M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-1.65-1.64-1.77-1.58-1.02-0.98-0.89-1.03-1.09-1.00-0.58-0.74-1.20-21.23-16.82-10.14-10.67-6.97-4.30-3.82
EPS Growth %-61.76%-67.35%-98.88%-53.4%6.42%2%-53.45%-39.19%9.17%95.29%96.55%92.7%88.75%-204.59%-291.16%-165.44%-79.33%-3385%--
EPS (Basic)-1.65-1.64-1.77-1.58-1.02-0.98-0.89-1.03-1.09-1.00-0.58-0.74-1.20-21.23-16.82-10.14-10.67-6.97-4.30-3.82
Diluted Shares Outstanding38.49M35.3M35.18M35.02M33.32M29.94M29.94M25.65M24.81M23.56M24.32M21.48M18.95M999.9K960.32K944.71K923.75K2.56M4.31M4.3M
Basic Shares Outstanding38.49M35.3M35.18M35.02M33.32M29.93M29.94M25.65M24.81M23.56M24.32M21.48M18.95M999.9K960.32K944.71K923.75K2.56M4.31M4.3M
Dividend Payout Ratio--------------------